Nrf2 siRNA treatment of macrophages of COPD patients and of a Nrf2–/– murine model of COPD has confirmed improved bacterial clearance secondary to an Nrf2-dependent up-regulation of MARCO (Harvey et al., 2011). This evidence concerns the gene GABPA and chronic obstructive pulmonary disease.